Theranostic nanocarriers | Contrast agents | Particle size | Therapeutic agents | Targeting moieties | Cancer cell lines | Animal models | References |
---|---|---|---|---|---|---|---|
YVO4:Eu3 + @MSN | YVO4:Eu3 +  |  ~ 375 nm | DOX | None | HeLa cells | None | [68] |
YVO4:Eu3C and Fe 3O4-MSN | YVO4:Eu3C |  ~ 50 nm | DOX | None | HeLa and MCF-7 cells | None | [69] |
M-MSN | MnFe2O4 |  ~ 100–150 nm | DOX | Folic acid | HeLa cells | Albino mice | [70] |
pMMSN | Not used for imaging purpose | 175.7 ± 11.4 nm | DOX | None | None | S180 tumor bearing mice | [71] |
MMS | Not used for imaging purpose |  ~ 150 nm | DOX | None | HeLa cells | None | [72] |
IONP | IONP |  ~ 4–10 nm | DOX | Folic acid | HeLa cells | None | [72] |
MSN-IONP | IONP | 60 ± 2 nm | None | None | LNCaP cells | LNCaP tumor bearing nude mice | [73] |
Au@SPIONs | SPION |  ~ 19 nm | None | MUC-1 aptamer | L929 and HT-29 cells | None | [74] |
GoMe | Gold nanoparticle | 50.87 ± 10.69 nm | DOX | None | A2058 cells | Lung tumor bearing FVB mice | [75] |
SPION | SPION | Not reported | None | Hyaluronic acid | MDA-MB-231 cells | MDA-MB-231 tumor-bearing mice | [76] |
Au@MSN | Gold nanoparticle |  ~ 63.12 nm | 5-FU | EpCAM aptamer | HepG2 cells | HepG2 tumor bearing nude mice | [16] |
SPION | SPION |  ~ 58 nm | siRNA | Folic acid | SGC-7901 cells | None | [77] |
MMSN | Not used for imaging purpose | 18.68 ± 2.31 nm | Epi | None | C26 cells | C26 tumor bearing mice | [78] |
SPION | SPION | Below 170Â nm | DOX | Folic acid | HCT116 and MCF-7 cells | HCT116 tumor bearing mice | [79] |
MSN-EuGd | EuGd |  ~ 120 nm | None | Hyaluronic acid and TAT peptide | A549 cells | None | [80] |
MMSNs | SPION | 89.88 ± 4.7 nm | DOX | AS1411 aptamer | MCF-7 cells | None | [59] |
SPION@MSN | Not used for imaging purpose |  ~ 27–50 nm | DOX | MUC-1 aptamer | MCF-7 cells | None | [60] |
HMSNsCS-CuS | CuS | 150 ± 13 nm | DOX | None | MDA-MB-231 cells | MDA-MB-231 tumor bearing nude mice | [81] |